Company expands Structural Heart Portfolio with the first commercially available bipolar temporary pacing guidewire designed specifically for use during transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV) WAYNE, Pa., June 07, 2023 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced […]
Other News
Karoo Health Raises $3.4 Million in Oversubscribed Seed Round
Funding Supports the Launch of the Only Value-based Cardiac Care Enablement Model in Partnership with up to 100 Cardiology Providers ALBUQUERQUE, N.M., June 7, 2023 /PRNewswire/ — Karoo Health, the only provider of cardiac value-based care enablement, announced today the closing of an oversubscribed Seed round of $3.4 million, with First Trust Capital Partners, […]
First Cohort of Heart Failure Specialists to Earn Heart Failure Certification (HF-Cert™) Announced by Heart Failure Society of America
ROCKVILLE, Md., June 7, 2023 /PRNewswire/ — The Heart Failure Society of America (HFSA) today announced the first cohort of heart failure (HF) providers to earn the Heart Failure Certification (HF-Cert). The multi-disciplinary certification recognizes HF providers who have demonstrated advanced-level knowledge and skill to provide competent heart failure services in the United […]
AliveCor collaborates with European market leader in remote patient monitoring Luscii to offer world’s first ‘virtual heart clinic in a box’
AMSTERDAM, June 7, 2023 /PRNewswire/ — AliveCor, the global leader in personal electrocardiogram (ECG) technology, has announced a groundbreaking collaboration with Luscii, Europe’s market leader in remote patient monitoring and virtual ward provider. Together, the companies will launch the world’s first ‘virtual heart clinic in a box’, revolutionising cardiac care for millions of patients […]
Ionis announces proposed private placement of convertible notes
CARLSBAD, Calif., June 6, 2023 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it intends to offer, subject to market conditions and other factors, $500.0 million aggregate principal amount of Convertible Senior Notes due 2028 (the “notes”) in a private placement (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the […]
Innova Vascular Earns FDA Clearance for Two New Thrombectomy Devices: Laguna Clot Retriever™ System and Malibu Aspiration Catheter™ System
IRVINE, Calif, June 7, 2023 /PRNewswire/ — Innova Vascular, Inc. announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Laguna Clot Retriever™ System and its Malibu Aspiration Catheter™ System for use in the peripheral vasculature. The two new devices are collectively known as the Laguna Thrombectomy System. […]
Translumina bolsters its German presence with acquisition of Lamed GmbH
NEW DELHI and MUNICH, June 7, 2023 /PRNewswire/ — Translumina, a global leader in interventional cardiovascular medical devices with manufacturing presence in Germany and India, today announced the acquisition of Munich-based Lamed GmbH. With this acquisition, Translumina has taken a step further towards its stated goal of providing a comprehensive cardiovascular portfolio at scale across key markets globally. […]
Bitterroot Bio Launches Out of Stealth with $145 Million Series A Financing to Develop Transformative Medicines in Cardio-immunology
Founders, Executive Team, and Advisors are recognized scientific and clinical pioneers in the fields of immunology and cardiology Series A financing co-led by ARCH Venture Partners and Deerfield Management with participation from GV, Koch Disruptive Technologies, Alexandria Venture Investments, and others PALO ALTO, Calif., June 07, 2023 (GLOBE NEWSWIRE) — […]
Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer
Bill Little, previously Chief Operating Officer (COO) of Neovasc, Inc. through its acquisition by Shockwave Medical in April 2023, will lead efforts to forge further strategic collaborations in newly created Executive Vice President (EVP) of Corporate Development and Strategy role Andrew Taylor joins as Chief Financial Officer (CFO) with over […]
Gore announces first U.S. enrollment for the GORE® VIAFORT Vascular Stent iliofemoral Study
CAUTION: Investigational device. Limited by United States law to investigational use. FIRST U.S. PATIENT ENROLLED IN GORE® VIAFORT Vascular Stent ILIOFEMORAL pivotal study FLAGSTAFF, Ariz., June 6, 2023 /PRNewswire/ — W. L. Gore & Associates (Gore) has announced that the first U.S. patient has been enrolled in a prospective, non-randomized, multicenter, single-arm study with five-year follow-up […]



